Chicago, ILNCT04477330Now EnrollingIRB Ready

Stroke Clinical Trial in Chicago, IL

Access cutting-edge stroke treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Illinois at Chicago

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access stroke specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stroke treatment provided free

Apply for This Chicago Location

Check if you qualify for this stroke clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Stroke Study in Chicago

Achieving functional ambulation post stroke continues to be a challenge for stroke survivors, clinicians, and researchers. In the effort to enhance outcomes of motor training, cortical priming using brain stimulation has emerged as a promising adjuvant to conventional rehabilitation. This project focuses on the development of a long term gait rehabilitation protocol using brain stimulation to improve walking outcomes in people with stroke. The project will also aim to understand the neural mechanisms that are associated with response to the intervention.

Sponsor: University of Illinois at Chicago

Who Can Participate

Inclusion Criteria

Age greater than 18 years
First ever monohemispheric stroke \> 3 months since onset
Residual hemiparetic gait deficits (e.g. abnormal gait pattern)
Able to walk for 5 minutes at self-paced speed. Handheld assistive device is acceptable.
Walking speed lesser than 1.2 m/s
Lower limb Fugl-Meyer Motor score between 15-30
At least 5 deg of ankle dorsiflexion necessary to perform the ankle-tracking task

Exclusion Criteria

General exclusion criteria
Severe osteoporosis
Contracture-limiting range of motion of lower limb
Score of more than 2 on the Modified Ashworth Scale (indicating increased muscle tone through ankle range of motion)
Uncontrolled anti-spasticity medications during the study period
Score less than 6 on the Fugl-Meyer Sensory Assessment Scale for the Lower Limb
Cardiorespiratory or metabolic diseases (e.g. cardiac arrhythmia, uncontrolled hypertension or diabetes, chronic emphysema)
Unhealed decubiti, persistent infection
Significant cognitive or communication impairment (Mini-Mental State Examination (MMSE)\<21), which could impede the understanding of the purpose of procedures of the study or prevent the patient from performing the ankle-tracking task.
Lesions involving the brainstem and cerebellum
Failure to pass the graded exercise stress test TMS exclusion criteria
Implanted cardiac pacemaker
Metal implants in the head or face
Unexplained, recurring headaches
History of seizures or epilepsy
Currently under medication that could increase motor excitability and lower seizure threshold
Skull abnormalities or fractures
Concussion within the last 6 months
Currently pregnant tDCS exclusion criteria
Skin hypersensitivity
History of contact dermatitits
History of allodynia and/or hyperalgesia
Any other skin or scalp condition that could be aggravated by tDCS

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT04477330) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stroke Treatment Options in Chicago, IL

If you're searching for stroke treatment options in Chicago, IL, this clinical trial (NCT04477330) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stroke clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Chicago, IL

See all stroke clinical trials recruiting in Chicago — not just this study.

Browse Stroke Trials in Chicago →

Browse More Trials by Condition

Stroke TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL